IL297355B2 - Tumor bed implant for multimodality treatment of at risk tissue surrounding a resection cavity - Google Patents
Tumor bed implant for multimodality treatment of at risk tissue surrounding a resection cavityInfo
- Publication number
- IL297355B2 IL297355B2 IL297355A IL29735522A IL297355B2 IL 297355 B2 IL297355 B2 IL 297355B2 IL 297355 A IL297355 A IL 297355A IL 29735522 A IL29735522 A IL 29735522A IL 297355 B2 IL297355 B2 IL 297355B2
- Authority
- IL
- Israel
- Prior art keywords
- polymer
- radiation
- seeds
- tissue
- implant
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims description 162
- 238000011228 multimodal treatment Methods 0.000 title 1
- 229920000642 polymer Polymers 0.000 claims description 267
- 230000005855 radiation Effects 0.000 claims description 186
- 239000007943 implant Substances 0.000 claims description 166
- 238000002271 resection Methods 0.000 claims description 158
- 239000011162 core material Substances 0.000 claims description 106
- 238000011282 treatment Methods 0.000 claims description 104
- 238000010438 heat treatment Methods 0.000 claims description 63
- 230000005291 magnetic effect Effects 0.000 claims description 59
- 239000000463 material Substances 0.000 claims description 46
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 45
- 239000000696 magnetic material Substances 0.000 claims description 38
- 230000002285 radioactive effect Effects 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 23
- 230000008878 coupling Effects 0.000 claims description 20
- 238000010168 coupling process Methods 0.000 claims description 20
- 238000005859 coupling reaction Methods 0.000 claims description 20
- 238000003780 insertion Methods 0.000 claims description 11
- 230000037431 insertion Effects 0.000 claims description 11
- 239000012857 radioactive material Substances 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000011553 magnetic fluid Substances 0.000 claims description 8
- 230000007704 transition Effects 0.000 claims description 5
- 230000006698 induction Effects 0.000 claims description 3
- 239000011800 void material Substances 0.000 claims description 3
- 239000006247 magnetic powder Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 178
- 238000002725 brachytherapy Methods 0.000 description 44
- 238000000034 method Methods 0.000 description 41
- 230000005294 ferromagnetic effect Effects 0.000 description 35
- 206010020843 Hyperthermia Diseases 0.000 description 31
- 230000036031 hyperthermia Effects 0.000 description 31
- 239000012530 fluid Substances 0.000 description 30
- 238000001959 radiotherapy Methods 0.000 description 28
- 230000001225 therapeutic effect Effects 0.000 description 28
- 238000002512 chemotherapy Methods 0.000 description 25
- 238000012384 transportation and delivery Methods 0.000 description 24
- 239000011248 coating agent Substances 0.000 description 22
- 238000000576 coating method Methods 0.000 description 22
- 238000009169 immunotherapy Methods 0.000 description 22
- 238000001356 surgical procedure Methods 0.000 description 22
- 239000010410 layer Substances 0.000 description 21
- 238000013459 approach Methods 0.000 description 19
- 229920000249 biocompatible polymer Polymers 0.000 description 18
- 239000003814 drug Substances 0.000 description 18
- 230000008901 benefit Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 230000000973 chemotherapeutic effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 14
- 210000004556 brain Anatomy 0.000 description 13
- 239000002245 particle Substances 0.000 description 12
- 239000002861 polymer material Substances 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 208000003174 Brain Neoplasms Diseases 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 125000006850 spacer group Chemical group 0.000 description 11
- 238000004980 dosimetry Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000002105 nanoparticle Substances 0.000 description 9
- 231100000419 toxicity Toxicity 0.000 description 9
- 230000001988 toxicity Effects 0.000 description 9
- 239000002671 adjuvant Substances 0.000 description 8
- 208000005017 glioblastoma Diseases 0.000 description 8
- 210000003739 neck Anatomy 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 7
- 238000003491 array Methods 0.000 description 7
- 239000003302 ferromagnetic material Substances 0.000 description 7
- 239000006249 magnetic particle Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 238000002604 ultrasonography Methods 0.000 description 7
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 208000014829 head and neck neoplasm Diseases 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 239000011247 coating layer Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 210000000867 larynx Anatomy 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 210000003625 skull Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 4
- 206010023841 laryngeal neoplasm Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 238000000015 thermotherapy Methods 0.000 description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 3
- 206010023825 Laryngeal cancer Diseases 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 229940127089 cytotoxic agent Drugs 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002710 external beam radiation therapy Methods 0.000 description 3
- 239000008240 homogeneous mixture Substances 0.000 description 3
- 230000001024 immunotherapeutic effect Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 210000005010 torso Anatomy 0.000 description 3
- 238000009827 uniform distribution Methods 0.000 description 3
- 206010018338 Glioma Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000000617 arm Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229960005243 carmustine Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000000191 radiation effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 238000011277 treatment modality Methods 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 235000012431 wafers Nutrition 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- 239000010965 430 stainless steel Substances 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003173 Arterial rupture Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010023856 Laryngeal squamous cell carcinoma Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010067362 Radiation necrosis Diseases 0.000 description 1
- 206010038111 Recurrent cancer Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 208000037842 advanced-stage tumor Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 201000006517 essential tremor Diseases 0.000 description 1
- 239000011554 ferrofluid Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229940084910 gliadel Drugs 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000029824 high grade glioma Diseases 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 230000002977 hyperthermial effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000011614 malignant glioma Diseases 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 239000000082 organ preservation Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000013439 planning Methods 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- -1 radiation seeds Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
- 231100000402 unacceptable toxicity Toxicity 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1014—Intracavitary radiation therapy
- A61N5/1015—Treatment of resected cavities created by surgery, e.g. lumpectomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; Determining position of diagnostic devices within or on the body of the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
- A61N5/022—Apparatus adapted for a specific treatment
- A61N5/025—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1027—Interstitial radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
- A61M2025/1013—Multiple balloon catheters with concentrically mounted balloons, e.g. being independently inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1024—Seeds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Optics & Photonics (AREA)
- Human Computer Interaction (AREA)
- Radiation-Therapy Devices (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Magnetic Treatment Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Prostheses (AREA)
- Medicinal Preparation (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315839P | 2016-03-31 | 2016-03-31 | |
| PCT/US2017/025523 WO2017173352A1 (en) | 2016-03-31 | 2017-03-31 | Tumor bed implant for multimodality treatment of at risk tissue surrounding a resection cavity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL297355A IL297355A (en) | 2022-12-01 |
| IL297355B1 IL297355B1 (en) | 2023-07-01 |
| IL297355B2 true IL297355B2 (en) | 2023-11-01 |
Family
ID=59965301
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL297355A IL297355B2 (en) | 2016-03-31 | 2017-03-31 | Tumor bed implant for multimodality treatment of at risk tissue surrounding a resection cavity |
| IL261962A IL261962B2 (en) | 2016-03-31 | 2018-09-26 | Tumor fundograft for multimodal treatment of tissue at risk around the surgical space |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL261962A IL261962B2 (en) | 2016-03-31 | 2018-09-26 | Tumor fundograft for multimodal treatment of tissue at risk around the surgical space |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11911631B2 (https=) |
| EP (2) | EP3954434A3 (https=) |
| JP (2) | JP7181549B2 (https=) |
| BR (1) | BR112018070259A2 (https=) |
| DK (1) | DK3454737T3 (https=) |
| IL (2) | IL297355B2 (https=) |
| PL (1) | PL3454737T3 (https=) |
| WO (1) | WO2017173352A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3481284T (pt) | 2016-07-07 | 2021-10-14 | Univ California | Implantes utilizando retrodifusão ultrassónica para detetar sinais eletrofisiológicos |
| WO2018227165A1 (en) * | 2017-06-08 | 2018-12-13 | Neuronoff, Inc. | Electrode cured and manufactured in the body, and related methods and devices |
| WO2019099813A1 (en) * | 2017-11-17 | 2019-05-23 | Musara Mubayiwa Cornelious | Multilayered biologic mesh and methods of use thereof |
| AU2019200986A1 (en) | 2018-02-22 | 2019-09-05 | Robert E. Sandstrom | Magnetic Field Enhancement of Chemotherapy for Tumor Treatment |
| CN111902165A (zh) | 2018-03-07 | 2020-11-06 | 马金-克利尔私人有限公司 | 局部近距放射治疗装置和治疗恶性癌细胞的方法 |
| KR102735457B1 (ko) * | 2018-03-08 | 2024-11-28 | 알파 타우 메디컬 리미티드 | 방사선 요법 시드 및 어플리케이터 |
| CN108714276B (zh) * | 2018-06-15 | 2021-06-01 | 李大鹏 | 一种妇科肿瘤腔内放射治疗防护装置 |
| WO2020205739A1 (en) * | 2019-03-31 | 2020-10-08 | The Trustees Of The University Of Pennsylvania | 'smart' hydrogel for the radiosensitization and sustained delivery of therapeutics triggered by irradiation |
| ES3044226T3 (en) | 2019-07-10 | 2025-11-26 | David Cohen | Apparatus for treatment of tumors using a treatment object and powering of the treatment object |
| CA3179536A1 (en) * | 2020-04-06 | 2021-10-14 | Tepha, Inc. | Medical implants for marking surgical sites |
| GR1010153B (el) * | 2020-09-21 | 2022-01-19 | Κυριακη Ιωαννη Θεοδωρου | Τρισδιαστατος συμμορφος εφαρμοστης για διεγχειρητικη ακτινοθεραπεια |
| JP2024511073A (ja) * | 2021-03-19 | 2024-03-12 | ジーティー メディカル テクノロジーズ、インコーポレイテッド | カスタム小線源治療キャリア |
| US20240269462A1 (en) * | 2021-07-28 | 2024-08-15 | Neuronoff, Inc. | Extension of a previously implanted lead or electrode |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050021088A1 (en) * | 2001-10-29 | 2005-01-27 | Schuler Peter S. | Systems containing temperature regulated medical devices, and methods related thereto |
| US20080146862A1 (en) * | 2006-04-21 | 2008-06-19 | North American Scientific, Inc. | Brachytherapy Device Having Seed Tubes With Individually-Settable Tissue Spacings |
| US20090054721A1 (en) * | 2007-08-24 | 2009-02-26 | Martin Gregory T | Fluid radiation shield for brachytherapy |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6099457A (en) * | 1990-08-13 | 2000-08-08 | Endotech, Inc. | Endocurietherapy |
| JPH04116146A (ja) | 1990-09-04 | 1992-04-16 | Riken Corp | ポリマー被覆した感温性アモルファス合金 |
| US5429582A (en) | 1991-06-14 | 1995-07-04 | Williams; Jeffery A. | Tumor treatment |
| ATE297787T1 (de) | 1994-12-27 | 2005-07-15 | Olympus Optical Co | Medizinische vorrichtung |
| JPH09122260A (ja) | 1995-11-02 | 1997-05-13 | Olympus Optical Co Ltd | 治療装置 |
| US6589502B1 (en) | 1995-11-27 | 2003-07-08 | International Brachytherapy S.A. | Radioisotope dispersed in a matrix for brachytherapy |
| US6254570B1 (en) | 1997-04-07 | 2001-07-03 | Vance Products, Inc. | Back-up retention member drainage catheter |
| US5976067A (en) | 1997-05-28 | 1999-11-02 | Ablation Technologies, Inc. | Combination radioactive and temperature self-regulating thermal seed implant for treating tumors |
| US6248057B1 (en) * | 1998-07-28 | 2001-06-19 | Innerdyne, Inc. | Absorbable brachytherapy and chemotherapy delivery devices and methods |
| US8068897B1 (en) * | 1999-03-01 | 2011-11-29 | Gazdzinski Robert F | Endoscopic smart probe and method |
| US6641519B1 (en) | 1999-07-23 | 2003-11-04 | Nucletron B.V. | Wire drive in a medical device |
| EP1129990A1 (en) * | 2000-02-25 | 2001-09-05 | Lucent Technologies Inc. | Process for controlled growth of carbon nanotubes |
| AU2003267309A1 (en) | 2000-11-16 | 2004-04-08 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
| US6527693B2 (en) | 2001-01-30 | 2003-03-04 | Implant Sciences Corporation | Methods and implants for providing radiation to a patient |
| US20030088145A1 (en) | 2001-07-18 | 2003-05-08 | Scott William Tate | Methods and devices for staged thermal and radiation therapy |
| US6761680B2 (en) | 2001-11-02 | 2004-07-13 | Richard A. Terwilliger | Delivery system and method for interstitial radiation therapy using seed strands constructed with preformed strand housing |
| US20040167506A1 (en) * | 2003-02-25 | 2004-08-26 | Scimed Life Systems, Inc. | Medical devices employing ferromagnetic heating |
| US20050090732A1 (en) | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
| US20060010475A1 (en) * | 2004-07-07 | 2006-01-12 | Sun Ningjun | High-spectrum radio frequency wireless transmission and control system for audio/video equipment |
| US7662082B2 (en) * | 2004-11-05 | 2010-02-16 | Theragenics Corporation | Expandable brachytherapy device |
| US8617152B2 (en) | 2004-11-15 | 2013-12-31 | Medtronic Ablation Frontiers Llc | Ablation system with feedback |
| US20070173680A1 (en) * | 2005-12-29 | 2007-07-26 | Boston Scientific Scimed, Inc | Apparatus and method for performing therapeutic tissue ablation and brachytherapy |
| WO2007106531A1 (en) | 2006-03-14 | 2007-09-20 | C.R. Bard, Inc. | Implant comprising radioactive seeds |
| RU2322199C1 (ru) | 2006-11-20 | 2008-04-20 | Илья Леонидович Васильченко | Способ лечения злокачественных опухолей гортани и гортаноглотки |
| US20080146861A1 (en) | 2006-12-18 | 2008-06-19 | Goshen Health System, Inc. | Brachytherapy Shielding System |
| US8287442B2 (en) | 2007-03-12 | 2012-10-16 | Senorx, Inc. | Radiation catheter with multilayered balloon |
| US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
| JP2010233682A (ja) | 2009-03-30 | 2010-10-21 | Olympus Corp | カテーテル |
| US20110118600A1 (en) | 2009-11-16 | 2011-05-19 | Michael Gertner | External Autonomic Modulation |
| EP2496165B1 (en) | 2009-11-04 | 2017-01-11 | Emcision Limited | Lumenal remodelling device |
| US8262619B2 (en) | 2010-09-30 | 2012-09-11 | Tyco Healthcare Group Lp | Introducer sheath for catheters |
| US9060761B2 (en) * | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
| JP2014516614A (ja) | 2011-04-08 | 2014-07-17 | コビディエン エルピー | 自然管腔又は人口管腔のための可撓性マイクロ波カテーテル |
| WO2012149580A1 (en) | 2011-04-28 | 2012-11-01 | Thomas, Theresa | Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors |
| JP6472133B2 (ja) | 2011-08-26 | 2019-02-20 | エンドマグネティクス リミテッド | 体腔および腔様の部分における癌を治療するためのエネルギー場を発生する装置 |
| WO2013044166A1 (en) | 2011-09-23 | 2013-03-28 | Schwartz Alan N | Non-invasive and minimally invasive and tightly targeted minimally invasive therapy methods and devices for parathyroid treatment |
| NL2009699C2 (en) | 2012-10-25 | 2014-04-29 | Nucletron Operations Bv | A modular applicator for brachytherapy. |
| US9662511B2 (en) | 2012-11-05 | 2017-05-30 | Nucletron Operations B.V. | Methods of making a medical applicator |
| US9149653B2 (en) | 2013-03-06 | 2015-10-06 | Mark A. D'Andrea | Brachytherapy devices and methods for therapeutic radiation procedures |
| CA2915384C (en) | 2013-06-20 | 2017-11-07 | Spec Med Intellectual Property, Llc | Radioactive therapeutic device with fixation |
| CN106132484B (zh) | 2014-05-28 | 2019-09-06 | 核通业务有限公司 | 用于基于成像数据的近距离放射治疗计划的方法和系统 |
| CN107530047B (zh) | 2015-04-10 | 2020-06-12 | 核通运营有限公司 | 短距离放射疗法系统 |
| US20170065324A1 (en) * | 2015-09-09 | 2017-03-09 | Rowan University | Wireless ablation catheter assembly |
| US10898728B2 (en) | 2015-10-30 | 2021-01-26 | Koninklijke Philips N.V. | Adaptive treatment planning for hyperthermia-enhanced radiation therapy |
-
2017
- 2017-03-31 IL IL297355A patent/IL297355B2/en unknown
- 2017-03-31 EP EP21183933.7A patent/EP3954434A3/en active Pending
- 2017-03-31 EP EP17776835.5A patent/EP3454737B1/en active Active
- 2017-03-31 DK DK17776835.5T patent/DK3454737T3/da active
- 2017-03-31 WO PCT/US2017/025523 patent/WO2017173352A1/en not_active Ceased
- 2017-03-31 PL PL17776835T patent/PL3454737T3/pl unknown
- 2017-03-31 BR BR112018070259A patent/BR112018070259A2/pt not_active Application Discontinuation
- 2017-03-31 JP JP2018551372A patent/JP7181549B2/ja active Active
- 2017-03-31 US US16/086,733 patent/US11911631B2/en active Active
-
2018
- 2018-09-26 IL IL261962A patent/IL261962B2/en unknown
-
2022
- 2022-11-10 JP JP2022179986A patent/JP7445232B2/ja active Active
-
2024
- 2024-01-18 US US18/416,340 patent/US20240181274A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050021088A1 (en) * | 2001-10-29 | 2005-01-27 | Schuler Peter S. | Systems containing temperature regulated medical devices, and methods related thereto |
| US20080146862A1 (en) * | 2006-04-21 | 2008-06-19 | North American Scientific, Inc. | Brachytherapy Device Having Seed Tubes With Individually-Settable Tissue Spacings |
| US20090054721A1 (en) * | 2007-08-24 | 2009-02-26 | Martin Gregory T | Fluid radiation shield for brachytherapy |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019511308A (ja) | 2019-04-25 |
| JP2023001313A (ja) | 2023-01-04 |
| EP3954434A2 (en) | 2022-02-16 |
| BR112018070259A2 (pt) | 2019-01-29 |
| DK3454737T3 (da) | 2021-10-11 |
| JP7181549B2 (ja) | 2022-12-01 |
| US20190099618A1 (en) | 2019-04-04 |
| IL297355B1 (en) | 2023-07-01 |
| US11911631B2 (en) | 2024-02-27 |
| PL3454737T3 (pl) | 2022-02-07 |
| IL261962B (en) | 2022-11-01 |
| US20240181274A1 (en) | 2024-06-06 |
| IL261962A (en) | 2018-10-31 |
| IL261962B2 (en) | 2023-03-01 |
| IL297355A (en) | 2022-12-01 |
| JP7445232B2 (ja) | 2024-03-07 |
| EP3954434A3 (en) | 2022-05-18 |
| EP3454737A4 (en) | 2020-01-22 |
| WO2017173352A1 (en) | 2017-10-05 |
| EP3454737A1 (en) | 2019-03-20 |
| EP3454737B1 (en) | 2021-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240181274A1 (en) | Tumor bed implant for multimodality treatment of at risk tissue surrounding a resection cavity | |
| Kok et al. | Heating technology for malignant tumors: a review | |
| MacDonell et al. | Magnetic resonance–guided interstitial high-intensity focused ultrasound for brain tumor ablation | |
| Lee et al. | Stereotactic laser interstitial thermal therapy for recurrent high-grade gliomas | |
| Pi et al. | Sonodynamic therapy on intracranial glioblastoma xenografts using sinoporphyrin sodium delivered by ultrasound with microbubbles | |
| US20250235255A1 (en) | Damaging cancerous cells utilizing radio frequency waves in heating with heating enhanced by infusion or injection of glucose | |
| Deger et al. | Interstitial hyperthermia using self-regulating thermoseeds combined with conformal radiation therapy | |
| Grady et al. | Magnetic stereotaxis: a technique to deliver stereotactic hyperthermia | |
| Cheng et al. | Simultaneous localized brain mild hyperthermia and blood-brain barrier opening via feedback-controlled transcranial MR-guided focused ultrasound and microbubbles | |
| Toccaceli et al. | Emerging strategies and future perspective in neuro-oncology using transcranial focused ultrasonography technology | |
| Sardari et al. | Cancer treatment with hyperthermia | |
| van Vulpen et al. | Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma—a feasibility study | |
| Gionso et al. | Focused Ultrasound for brain diseases: a review of current applications and future perspectives | |
| Kawai et al. | Safety of regional 8-mhz radiofrequency capacitive hyperthermia combined with magnetic cationic liposomes in patients with castration-resistant prostate cancer: A phase i clinical study | |
| US11771919B2 (en) | Hyperthermia brachytherapy device and method for treating tumors | |
| Dahiya | Brachytherapy: A review | |
| US12551719B2 (en) | Pulsating brachytherapy method and system | |
| Stauffer et al. | Dual modality implant for simultaneous magnetic nanoparticle heating and brachytherapy treatment of tumor resection cavities in brain | |
| US20240082600A1 (en) | Hyperthermia brachytherapy device and method for treating tumors | |
| Seegenschmiedt et al. | Clinical practice of interstitial thermoradiotherapy | |
| Lin et al. | Focused Ultrasound in Pediatric Neuro-Oncology: Current Applications and Future Directions | |
| Luk | Clinical application of interstitial hyperthermia | |
| WO2004075977A2 (en) | Methods using diffuse field ultrasound-induced hyperthermia | |
| Hiltbrand et al. | A new method of thermoablation with hot water vapour for localized tumours | |
| Trachtenberg et al. | Prostate cancer: 11. Alternative approaches and the future of treatment |